Inhibitors of hepatitis C virus polymerase
US9707215B2 · kind B2 · utility
3Cited by
7References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2013 |
| Grant date | Jul 18, 2017 |
| Priority date | — |
| Expiry date | Jun 20, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides, among other things, compounds represented by the general Formula I: and pharmaceutically acceptable salts thereof, wherein X, Y, R2, and R3 are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.